These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7307290)

  • 1. Endocrine effects of domperidone: a peripheral dopamine blocking agent.
    Brown GM; Verhaegan H; Van Wimersma Greidanus TB; Brugmans J
    Clin Endocrinol (Oxf); 1981 Sep; 15(3):275-82. PubMed ID: 7307290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of domperidone on apomorphine-induced growth hormone secretion in normal men.
    Lal S; Nair NP; Iskandar HL; Etienne P; Wood PL; Schwartz G; Guyda H
    J Neural Transm; 1982; 54(1-2):75-84. PubMed ID: 7108512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of GRF(1-40) and domperidone on GH secretion in normal man.
    Giusti M; Mazzocchi G; Sessarego P; Mignone D; Lomeo A; Monachesi M; Giordano G
    Clin Endocrinol (Oxf); 1984 Oct; 21(4):339-43. PubMed ID: 6439434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of metoclopramide, domperidone and apomorphine on GH secretion in children and adolescents.
    Massara F; Tangolo D; Godano A; Goffi S; Bertagna A; Molinatti GM
    Acta Endocrinol (Copenh); 1985 Apr; 108(4):451-5. PubMed ID: 3993312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth hormone inhibitory and stimulatory actions of L-dopa in patients with acromegaly.
    Hanew K; Sasaki A; Sato S; Goh M; Yoshinaga K
    J Clin Endocrinol Metab; 1987 Feb; 64(2):255-60. PubMed ID: 3793848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulatory control of prolactin by dopamine.
    Brown GM; Seggie JA
    Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(4-6):355-8. PubMed ID: 6891802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors in the control of prolactin, growth hormone and gonadotropin secretion in prepubertal rats.
    González LC; Pinilla L; Tena-Sempere M; Aguilar E
    J Endocrinol; 1999 Sep; 162(3):417-24. PubMed ID: 10467233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential TSH and PRL responses to dopamine receptor blockade in acromegaly.
    Prescott RW; Weightman DR; Kendall-Taylor P; Johnston DG
    Clin Endocrinol (Oxf); 1984 Oct; 21(4):369-75. PubMed ID: 6509782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of gamma-aminobutyric acid on growth hormone and prolactin secretion in man: influence of pimozide and domperidone.
    Cavagnini F; Benetti G; Invitti C; Ramella G; Pinto M; Lazza M; Dubini A; Marelli A; Müller EE
    J Clin Endocrinol Metab; 1980 Oct; 51(4):789-92. PubMed ID: 7419665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of aging on growth hormone and prolactin release after growth hormone-releasing hormone and domperidone in man.
    Giusti M; Lomeo A; Marini G; Attanasio R; Barreca A; Camogliano L; Peluffo F; Giordano G
    Horm Res; 1987; 27(3):134-40. PubMed ID: 3121487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tubero-infundibular dopaminergic function in cirrhotic patients: evaluation by nomifensine and domperidone.
    Monza GC; Lampertico M; Locatelli S; Sali L; Cocchi D
    Acta Endocrinol (Copenh); 1983 Jul; 103(3):315-20. PubMed ID: 6880568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma growth hormone and prolactin response to dopaminergic GABAmimetic and cholinergic stimulation in Huntington's disease.
    Durso R; Tamminga CA; Denaro A; Ruggeri S; Chase TN
    Neurology; 1983 Sep; 33(9):1229-32. PubMed ID: 6225034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCK-33 antagonizes apomorphine-induced growth hormone secretion and increases basal prolactin levels in man.
    Nair NP; Lal S; Thavundayil JX; Wood PL; Etienne P; Guyda H
    Neuropeptides; 1984 Jun; 4(4):281-91. PubMed ID: 6472582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of apomorphine on growth hormone and prolactin secretion in schizophrenic patients, with or without oral dyskinesia, withdrawn from chronic neuroleptic therapy.
    Ettigi P; Nair NP; Lal S; Cervantes P; Guyda H
    J Neurol Neurosurg Psychiatry; 1976 Sep; 39(9):870-6. PubMed ID: 993808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of dopamine receptor antagonists on gastrin and vomiting responses to apomorphine.
    Goiny M; Uvnäs-Moberg K
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Jul; 336(1):16-9. PubMed ID: 2888024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Domperidone: a new pharmacodynamic agent for exploration of the hypophysis (author's transl)].
    Bercovici JP; Khoury S; Tater D; Caroff J; Sudre Y; Besson G
    Nouv Presse Med; 1981 Jul; 10(29):2421-5. PubMed ID: 7255146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of domperidone on the secretion of prolactin from rat anterior pituitary glands.
    Bentley AM; Wallis M
    J Endocrinol; 1982 Sep; 94(3):317-26. PubMed ID: 7119643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The interaction of trh and dopaminergic mechanisms in the regulation of stimulated prolactin release in man.
    Ho KY; Smythe GA; Lazarus L
    Clin Endocrinol (Oxf); 1985 Jul; 23(1):7-16. PubMed ID: 3928213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. L-646,462, a cyproheptadine-related antagonist of dopamine and serotonin with selectivity for peripheral systems.
    Williams M; Martin GE; Remy DC; Hichens M; Mangel AW; Taylor DA; Yarbrough GG; Bendesky RJ; King SW; Robinson JL
    J Pharmacol Exp Ther; 1984 Jun; 229(3):775-81. PubMed ID: 6547178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The dopaminergic regulation of plasma growth hormone secretion in normal subjects.
    Hanew K; Sato S; Sasaki A; Goh M; Shimizu Y; Yoshinaga K
    Tohoku J Exp Med; 1986 Feb; 148(2):151-8. PubMed ID: 3961796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.